# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
B of A Securities analyst Joanna Gajuk maintains Chemed (NYSE:CHE) with a Buy and lowers the price target from $610 to $595.
Jefferies analyst Brian Tanquilut upgrades Chemed (NYSE:CHE) from Hold to Buy and raises the price target from $490 to $550.
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million fo...
RBC Capital analyst Ben Hendrix maintains Chemed (NYSE:CHE) with a Outperform and lowers the price target from $640 to $589.